Melhores Cancro do esófago médicos em Espanha - TOP-8 médicos

• O Dr. Jaume Capdevila é especializado no tratamento do câncer de esôfago, oferecendo quimioterapia, radioterapia, cirurgia e terapia alvo.
• Ele recebeu formação no Hospital Universitário de Uppsala, na Suécia, com foco em Oncologia Endócrina.
• Possui graduação em Medicina e Cirurgia pela Universidade de Lleida e especialização em Oncologia Médica.
• O Dr. Capdevila é membro da EORTC, ESMO, ENETS, ASCO, GEMCAD, TTD e GETHI.
• Ele fala vários idiomas, o que facilita a comunicação com pacientes de diversas origens.

Prof. Fermin Mearin Manrique is an experienced Spanish gastroenterologist with over 40 years of practice. He specializes in diagnostics and treatment of digestive system conditions, with a focus on functional digestive disorders management. He has extensive academic and professional experience, having written over 400 scientific works and being a member of numerous organizations.

• O Dr. Carlos Ballesta López é especializado no tratamento de câncer do esôfago, com mais de 30 anos de experiência.
• É especialista em cirurgia laparoscópica, que reduz a dor e o tempo de recuperação para pacientes com câncer do esôfago.
• As opções de tratamento padrão incluem ressecção endoscópica, esofagectomia, quimioterapia, radioterapia e terapia alvo.
• O Dr. López tem experiência internacional, tendo atuado em clínicas na Espanha e na América Latina.
• Ele é certificado pela IFSO como um Centro de Excelência em Cirurgia Bariátrica e Metabólica.

General and digestive tract surgeon with expertise in minimally invasive laparoscopic surgery. Has held Associate Clinical Lecturer and Lecturer positions at the University of Navarre School of Medicine. Member of the Spanish Association of Surgeons, Spanish Society of Obesity Surgery, and European Association for Endoscopic Surgery.

Dr. Sullivan graduated in Medicine and Surgery from the National University of Rosario in 2005, specializing in Medical Oncology through the MIR at the Santa Creu i Sant Pau Hospital (HSCiSP, 2012) in Barcelona.

She received a post-MIR scholarship from the Ministry of Interior from HSPiSP (2012) and then a pre-doctoral scholarship from ISCiii (Rio Hortega – 2013-2015).

In 2014, he moved to Paris where he obtained a DUERTECC diploma at the Gustave Roussy University Hospital (Villejuif), followed by an ESMO scholarship (Georges Mathé Translator Scholarship), which he received in 2016.

Since January 2017, he has been working on the staff of the Medical Oncology Department of the HSCiSP. In the same year, he obtained his PhD from the Autonomous University of Barcelona.

Since 2015, he has been a member of the Board of Directors of the Spanish Lung Cancer Group (GECP). And since 2022, he has been the coordinator of the HSCiSP Committee on Neuroendocrine Tumors.

In November 2021, she joined the IOR Medical Oncology Service and is actively involved in various research projects in the Pangea Lab under the supervision of Dr. Molina.

Dr. Sullivan is involved in several clinical trials in lung cancer and neuroendocrine tumors, many of which have been presented at various international scientific meetings.

She has participated in national and international conferences and is an author and co-author of research articles published in influential journals.

She is currently a member of the Spanish Society of Medical Oncology (SEOM), GECP, European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Group of Neuroendocrine and Endocrine Tumors (GETNE).

One of the world-renowned pioneers in gastrointestinal surgery. Has developed new techniques for the colon and rectum cancer treatment TaTMEТ and NOTES — applied now around the world.
Has performed over 15,000 surgeries.
Performs over 1,000 interventions a year using minimally invasive techniques.
President of the Association of Surgeons-Endoscopists in Europe.

Dr. López-Ibor is a specialist in Pediatric Hematology and Oncology. She earned her medical degree from the Complutense University of Madrid and her doctorate from the University of Barcelona. She is also accredited by the University of Maryland. Dr. López-Ibor treats bone and brain tumors, leukemia, and blood disorders.

She has over 20 years of experience. Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe Hospital. She has written many scientific articles, both nationally and internationally, and has made important contributions to her field.